Share this story:

Plantify Foods Reports Proposed Extension of Convertible Debentures



Plantify Foods, Inc.

Vancouver, British Columbia – TheNewswire – August 19, 2024 - Plantify Foods, Inc. (TSXV: PTFY) ("Plantify" or the "Company"), a clean label food company dedicated to providing consumers with nutritious and delicious food options, reports that it intends to amend its convertible debentures issued on July 29, 2022, and amended on August 23, 2023, in the aggregate principal sum of $290,000 (the “Debentures”).

Subject to receipt of TSX Venture Exchange acceptance, the Debentures will be further amended to extend their maturity date from August 29, 2024 to August 29, 2025.

The Debentures are convertible into units of the Company (“Units”) at a price of $0.05 per Unit. Each Unit will continue to consist of one common share of the Company (“Shares”) and one common share purchase warrant of the Company (“Warrants”). Each Warrant will be exercisable at a price of $0.05 per Share for a period of 24 months from the date of conversion of the Debenture.

About Plantify Foods, Inc.

Plantify is committed to providing consumers with nutritious, clean label food options while pioneering innovation in the food and beverage industry. The Company has a simple mission: to ensure that everyone has access to high quality food alternatives that are clean and healthy, are nutritious and tasty, use whole natural ingredients, and are easy to prepare.

Plantify, through its wholly owned Israeli subsidiary, currently sells its diverse range of products in Israel, and is actively expanding its footprint across Europe and North America.

If you have any questions or need more information, feel free to contact the Company directly.

Contacts:

Gabriel Kabazo

Chief Financial Officer and Corporate Secretary

Phone: (778) 601-8420

 

Investor Relations

Email: ir@plantifyfoods.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.